The Sant Pau Initiative on Neurodegeneration (SPIN) cohort: A data set for biomarker discovery and validation in neurodegenerative disorders

Daniel Alcolea, Jordi Clarimón, María Carmona-Iragui, Ignacio Illán-Gala, Estrella Morenas-Rodríguez, Isabel Barroeta, Roser Ribosa-Nogué, Isabel Sala, M. Belén Sánchez-Saudinós, Laura Videla, Andrea Subirana, Bessy Benejam, Sílvia Valldeneu, Susana Fernández, Teresa Estellés, Miren Altuna, Miguel Santos-Santos, Lídia García-Losada, Alexandre Bejanin, Jordi PeguerolesVíctor Montal, Eduard Vilaplana, Olivia Belbin, Oriol Dols-Icardo, Sònia Sirisi, Marta Querol-Vilaseca, Laura Cervera-Carles, Laia Muñoz, Raúl Núñez, Soraya Torres, M. Valle Camacho, Ignasi Carrió, Sandra Giménez, Constance Delaby, Ricard Rojas-Garcia, Janina Turon-Sans, Javier Pagonabarraga, Amanda Jiménez, Rafael Blesa, Juan Fortea, Alberto Lleó

Research output: Contribution to journalArticleResearch

16 Citations (Scopus)


© 2019 The Authors Introduction: The SPIN (Sant Pau Initiative on Neurodegeneration) cohort is a multimodal biomarker platform designed for neurodegenerative disease research following an integrative approach. Methods: Participants of the SPIN cohort provide informed consent to donate blood and cerebrospinal fluid samples, receive detailed neurological and neuropsychological evaluations, and undergo a structural 3T brain MRI scan. A subset also undergoes other functional or imaging studies (video-polysomnogram, 18F-fluorodeoxyglucose PET, amyloid PET, Tau PET). Participants are followed annually for a minimum of 4 years, with repeated cerebrospinal fluid collection and imaging studies performed every other year, and brain donation is encouraged. Results: The integration of clinical, neuropsychological, genetic, biochemical, imaging, and neuropathological information and the harmonization of protocols under the same umbrella allows the discovery and validation of key biomarkers across several neurodegenerative diseases. Discussion: We describe our particular 10-year experience and how different research projects were unified under an umbrella biomarker program, which might be of help to other research teams pursuing similar approaches.
Original languageEnglish
Pages (from-to)597-609
JournalAlzheimer's and Dementia: Translational Research and Clinical Interventions
Publication statusPublished - 1 Jan 2019


  • Alzheimer's disease
  • Biomarkers
  • Dementia with Lewy bodies
  • Frontontemporal dementia
  • Neurodegeneration
  • Neuroimaging


Dive into the research topics of 'The Sant Pau Initiative on Neurodegeneration (SPIN) cohort: A data set for biomarker discovery and validation in neurodegenerative disorders'. Together they form a unique fingerprint.

Cite this